Phentermine

VIVUS Provides Update on Pipeline and Program Milestones

Retrieved on: 
Monday, January 8, 2024

CAMPBELL, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs, today announced pipeline updates and program milestones.

Key Points: 
  • CAMPBELL, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs, today announced pipeline updates and program milestones.
  • “VIVUS has been continuously dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting diseases, including exocrine pancreatic insufficiency, obesity and pulmonary arterial hypertension,” said John Amos, Chief Executive Officer at VIVUS LLC.
  • QSYMIA® is now the number one branded oral product in the US for obesity treatment.
  • Moreover, VIVUS is actively developing pipeline products focusing on bone marrow transplant preparation (VI-0609) and diabetes treatments (VI-0809 and VI-0810).”

New Clinical Data Demonstrate that QSYMIA®, the Leading Once-Daily Oral Weight-Management Medication, Reduces Blood Pressure

Retrieved on: 
Tuesday, November 28, 2023

Obesity and high blood pressure are significant risk factors for the development of cardiovascular disease.

Key Points: 
  • Obesity and high blood pressure are significant risk factors for the development of cardiovascular disease.
  • “QSYMIA offers a differentiated profile consisting of demonstrated efficacy with respect to weight loss and blood pressure reduction, well-defined safety, convenient once-daily oral administration, and cost-effectiveness.
  • The once-daily pill is currently covered by the majority (81%) of commercial healthcare plans and is indicated for long-term use.
  • Importantly, obesity increases the risk of type 2 diabetes, hypertension and dyslipidemia, thereby increasing the risk of cardiovascular disease and mortality.

Ozempic is in the spotlight but it's just the latest in a long and strange history of weight-loss drugs

Retrieved on: 
Tuesday, August 8, 2023

That’s been the holy grail of weight-loss ever since 19th century English undertaker and weight-loss celebrity William Banting’s 1863 Letter on Corpulence spruiked his “miraculous” method of slimming down.

Key Points: 
  • That’s been the holy grail of weight-loss ever since 19th century English undertaker and weight-loss celebrity William Banting’s 1863 Letter on Corpulence spruiked his “miraculous” method of slimming down.
  • Since then, humans have tried many things – diet, exercise, psychotherapy, surgery – to lose weight.
  • But time and again we return to the promise of a weight-loss drug, whether it’s a pill, injection, or tonic.

Ozempic is a recent arrival

    • Ozempic and its sister drug Wegovy, both manufactured by Novo Nordisk, are the latest offerings in a long history of drug treatments for people who are overweight.
    • This has helped drive a shortage of Ozempic for diabetes treatment.

From ‘gland treatment’ to amphetamines

    • For example, organotherapy (gland treatment) was hugely popular in the 1920s to 1940s.
    • Doctors prescribed overweight people extracts of animal glands – either eaten raw or dried in pill form or injected – to treat their supposedly “sluggish glands”.
    • Amphetamines were first used as a nasal decongestant in the 1930s, but quickly found a market for weight-loss.
    • Amphetamines too, fell from treatment use in the 1970s with Nixon’s “war on drugs” and recognition they were addictive.

Another decade, another drug

    • For example, the popular diet drug of the 1980s and 90s was fen-phen, which contained appetite suppressants fenfluramine and phentermine.
    • And as history recognises, multiple complexities can combine to push a drug into popularity or damn it to history’s rubbish bin.
    • One noticeable contrast with past diet drug experiences is that now, many people are happy to talk about using Ozempic.
    • It seems to be increasingly socially acceptable to use a drug to achieve weight-loss for primarily aesthetic reasons.

Our enduring search for weight-loss drugs

    • Ozempic is predicted to earn Novo Nordisk US$12.5 billion this year alone, but it’s not just industry interests stoking this enduring desire for weight-loss drugs.
    • Patients on an endless cycle of dieting and exercise want something more convenient, with a more certain outcome.
    • It is no wonder demand for weight-loss drugs continues to soar.

Obesity-focused Organizations Issue Statement in Support of New AAP Clinical Guideline on Childhood Obesity

Retrieved on: 
Friday, January 13, 2023

On Jan. 9, 2023, AAP published its first clinical practice guideline on the treatment of childhood obesity, replacing recommendations last made in 2007.

Key Points: 
  • On Jan. 9, 2023, AAP published its first clinical practice guideline on the treatment of childhood obesity, replacing recommendations last made in 2007.
  • TOS and OAC support the evidence-based view of obesity presented in the guideline.
  • The Obesity Society's Pediatric Obesity Treatment Task Force emphasizes that pediatric obesity is a disease.
  • The Obesity Action Coalition (OAC) is a national nonprofit organization dedicated to elevating and empowering individuals affected by obesity through education, advocacy and support.

PFX Labs Release The Best Legal Phentermine Alternatives Chosen By Outlook India in 2022

Retrieved on: 
Thursday, August 11, 2022

Kington, Aug. 11, 2022 (GLOBE NEWSWIRE) -- PFX Labs impressive phentermine alternative ShredCBD won the vote by Outlook India as the best over the counter fat burning and weight loss solution with their range of successful studies and high-quality ingredients.

Key Points: 
  • Kington, Aug. 11, 2022 (GLOBE NEWSWIRE) -- PFX Labs impressive phentermine alternative ShredCBD won the vote by Outlook India as the best over the counter fat burning and weight loss solution with their range of successful studies and high-quality ingredients.
  • Winning a selection of prestigious awards, including the International Press Institute award for Excellence in Journalism, Outlook India has now drawn their attention to presenting to their readers the best and most effective phentermine alternatives for weight loss and management.
  • Their specialised phentermine alternative formula is safe and made with science-backed ingredients that have shown to help support peak metabolic health.
  • To read more about Outlook Indias article on PFX Labs ShredCBD and Wolfson Brands Ltd PhenQ, please visit their website at https://www.outlookindia.com/outlook-spotlight/alternatives-to-phentermi... .

Modern Medical Weight Loss Opens a Medical Weight Loss Clinic in Louisville, KY

Retrieved on: 
Wednesday, August 10, 2022

For decades doctors were limited to two options; Phentermine, (or Adipex), prescription stimulants that increase metabolism without curbing hunger--or gastric surgery. They insert a sleeve that restricts the amount of food the patient can physically eat. This is a serious surgery with a long recovery time, and it requires a lifetime of changed eating habits.

Key Points: 
  • LOUISVILLE, Ky., Aug. 10, 2022 /PRNewswire/ -- Modern Medical Weight Loss announces the grand opening of a new medical weight loss clinic in Louisville Kentucky, offering the most advanced medical weight loss formula in over two decades.
  • One practitioner, the doctor who developed the Modern Medical Weight Loss formula, felt it was time to approach the problem in a new way.
  • Modern Medical Weight Loss is open in Louisville, and ready to offer safe, effective weight loss therapy for those who schedule an in-person consultation by calling (502) 325-3380.
  • Modern Medical Weight Loss is a new medical weight loss practice offering an innovative protein-based therapy for those seeking to lose weight without a complicated hard to follow program, serious medications, or surgery.

Indy Medical Group Opens New Medical Weight Loss Clinic in Indianapolis

Retrieved on: 
Tuesday, August 9, 2022

Losing weight is the most important thing people can do to improve their overall health. Being at an optimum weight improves one's chances of having normal blood pressure, fewer aches and pains, and a more efficient digestive system. It also lowers the risk of developing serious diseases. Until now, doctors have been limited to two options; Phentermine, (or Adipex), stimulants that increase the metabolism without curbing hunger--or gastric surgery, a sleeve that restricts the amount of food you can physically eat. This is a serious surgery with a long recovery time and calls for a lifetime of changing one's eating habits.

Key Points: 
  • INDIANAPOLIS, Aug. 9, 2022 /PRNewswire/ -- Indy Medical Group announces the grand opening of a new medical weight loss clinic in Indianapolis, offering the most advanced medical weight loss therapy in over two decades.
  • The practitioner who developed the Indy Weight Loss therapy felt it was time to approach the problem in a new way and find a medical weight loss approach without surgery or serious medications.
  • Indy Medical Group is owned by a weight loss practitioner and a team of specialists trained to work with patients who need to lose weight, but desire to do so without invasive gastric bypass surgery or stimulant-based pharmaceuticals.
  • The Indy Medical Group is now open in Indianapolis and ready to offer safe, effective weight loss with an experienced team, and scheduling an in-person initial consultation is easy, just call 317-427-6050.

FDA Approves QSYMIA® for the Treatment of Obesity in Adolescents Ages 12-17

Retrieved on: 
Wednesday, July 20, 2022

According to the CDC, approximately 22% of children aged 12-19 years in the United States about 14 million individuals have obesity.

Key Points: 
  • According to the CDC, approximately 22% of children aged 12-19 years in the United States about 14 million individuals have obesity.
  • The increased prevalence of adolescent obesity in the United States and its associated short- and long-term complications underscore the need for safe and effective treatment.
  • As a company committed to innovating new solutions for the obesity crisis, the FDA approval of QSYMIA for the treatment of obesity in adolescents is an important milestone for our dedicated team, said Dr. Santosh T. Varghese, Senior Vice President, Chief Medical Officer of VIVUS LLC.
  • The data supporting the FDA approval of QSYMIA in treating obesity in adolescents demonstrated a significant reduction in BMI, mean body weight and other weight-related endpoints compared placebo in adolescents with obesity when using QSYMIA as an adjunct to lifestyle therapy.

Overweight Treatment Market estimated to surge ahead at a CAGR of 7.9% by the end of 2032 - Persistence Market Research

Retrieved on: 
Monday, June 6, 2022

Per capita healthcare spending is on the rise, which is predicted to fuel the demand for high-quality patient care treatment alternatives.

Key Points: 
  • Per capita healthcare spending is on the rise, which is predicted to fuel the demand for high-quality patient care treatment alternatives.
  • Developing economies such as Brazil, India, and Russia are expected to contribute significantly to the anti-obesity drug development industry.
  • By distribution channel, institutional sales are gaining higher traction for overweight treatment, and held a market value share of 58.2% in 2021.
  • "High incidence of morbid obesity and rising efforts to mitigate indications associated with overweight are driving sales in the overweight treatment market," says an analyst of Persistence Market Research.

Medical Weight Loss and Beauty Helps Californians Lose Weight and Feel Confident in Their Own Skin

Retrieved on: 
Wednesday, April 13, 2022

Medical Weight Loss and Beauty was founded by Dr. James Kojian M.D., a world-renowned expert in safe and effective anti-aging and weight loss treatments.

Key Points: 
  • Medical Weight Loss and Beauty was founded by Dr. James Kojian M.D., a world-renowned expert in safe and effective anti-aging and weight loss treatments.
  • As a weight loss clinic and medical spa rolled into one, Medical Weight Loss and Beauty has helped countless Californians achieve their weight loss goals and feel more confident in their own skin.
  • So, if youre looking for a fantastic phentermine weight loss service Pasadena , look no further than the Medical Weight Loss and Beauty clinic.
  • Medical Weight Loss and Beauty is a medically assisted weight loss clinic conveniently located in Pasadena, CA.